What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Genetic testing startup 23andMe, which filed for bankruptcy earlier this year, announced on Monday that it has agreed to sell ...

Me has found a buyer in biotech company Regeneron Pharmaceuticals. If you want your data removed, here are your options.

Me (ME) will have a second life. The genetic-testing company, which had a $6 billion valuation at the time of its 2021 IPO, ...

A court hearing to consider the transaction’s approval is scheduled for June 17, according to 23andMe Genetics company ...

The backup bidder to Regeneron is a nonprofit apparently started by former 23andMe CEO Anne Wojcicki. Meet the company that ...

Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy ...

It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...